AVI Biopharma, a Portland, OR-based developer of RNA-based drugs, said today it has secured a contract with the US Defense Threat Reduction Agency to develop.

More here:
AVI Developing Swine Flu Drugs | Xconomy

Related posts:

1. India developing indigenous swine flu vaccine (Interview) India is expected to be among the first few countries...
2. Vical says its developing swine flu vaccine prompts immune … Vical's swine flu vaccine works in mice, rabbitsSAN DIEGO —...
3. People at High Risk of Developing Flu-Related Complications Most people who get the flu (either seasonal or 2009...
4. Cannabis Science: Can Cannabis-Based Drugs Slow the H1N1 "Swine Flu" Pandemic? SAN FRANCISCO--(BUSINESS WIRE)--The World Health Organization declared a swine flu...
5. WHO: Early Signs H1N1 Developing Vaccine Resistance The swine flu virus hasn't mutated into a more deadly...

Related posts brought to you by Yet Another Related Posts Plugin.

Tags | being-mulled, bird flu, defense, defense-threat, dominion-post, green, indian-express, reduction, reduction-agency, rna, smith, swine, swine flu, upper